Related Experiment Video
Updated: Apr 17, 2026
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Microparticle analysis in disorders of hemostasis and thrombosis
Micah J Mooberry1, Nigel S Key1
1Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, North Carolina.
Abstract:
Microparticles (MPs) are submicron vesicles released from the plasma membrane of eukaryotic cells in response to activation or apoptosis. MPs are known to be involved in numerous biologic processes, including inflammation, the immune response, cancer metastasis, and angiogenesis. Their earliest recognized and most widely accepted role, however, is the ability to promote and support the process of blood coagulation. Consequently, there is ongoing interest in studying MPs in disorders of hemostasis and thrombosis. Both phosphatidylserine (PS) exposure and the presence of tissue factor (TF) in the MP membrane may account for their procoagulant properties, and elevated numbers of MPs in plasma have been reported in numerous prothrombotic conditions. To date, however, there are few data on true causality linking MPs to the genesis of thrombosis. A variety of methodologies have been employed to characterize and quantify MPs, although detection is challenging due to their submicron size. Flow cytometry (FCM) remains the most frequently utilized strategy for MP detection; however, it is associated with significant technological limitations. Additionally, preanalytical and analytical variables can influence the detection of MPs by FCM, rendering data interpretation difficult. Lack of methodologic standardization in MP analysis by FCM confounds the issue further, although efforts are currently underway to address this limitation. Moving forward, it will be important to address these technical challenges as a scientific community if we are to better understand the role that MPs play in disorders of hemostasis and thrombosis.
Insights
Microparticles (MPs), small cell-derived vesicles, are implicated in blood coagulation and thrombosis. Further research is needed to overcome detection challenges and establish a causal link between MPs and thrombosis development.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Microparticles (MPs) are submicron vesicles released from cell membranes during activation or apoptosis.
- MPs play roles in inflammation, immunity, cancer, and angiogenesis, with a key function in promoting blood coagulation.
- Elevated plasma MP levels are observed in prothrombotic conditions, suggesting a role in hemostasis and thrombosis disorders.
Purpose of the Study:
- To investigate the role of microparticles in hemostasis and thrombosis.
- To highlight the procoagulant properties of MPs, including phosphatidylserine exposure and tissue factor presence.
- To address the challenges in accurately detecting and quantifying MPs for reliable data interpretation.
Main Methods:
- Characterization and quantification of microparticles using various methodologies.
- Flow cytometry (FCM) is the primary method for MP detection, despite inherent technological limitations.
- Analysis of preanalytical and analytical variables influencing MP detection by FCM.
Main Results:
- MPs possess procoagulant properties due to phosphatidylserine exposure and tissue factor.
- Elevated MP numbers correlate with prothrombotic states, but direct causal links to thrombosis genesis are not well-established.
- Flow cytometry, while widely used, faces significant limitations in MP detection and data interpretation.
Conclusions:
- Microparticles are significant players in blood coagulation and may contribute to thrombosis.
- Current methodologies, particularly flow cytometry, require standardization and improvement for accurate MP analysis.
- Further research addressing technical challenges is crucial to elucidate the precise role of MPs in hemostasis and thrombosis.
Related Concept Videos
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...